Caplin Point arm gets USFDA nod for milrinone lactate in 5 pc dextrose injection

Caplin Point Laboratories' arm, Caplin Steriles, secured USFDA approval for its generic milrinone lactate in 5% dextrose injection. Indicated for acute decompensated heart failure, the injection is a generic version of Sanofi Aventis' PRIMACOR. The US market for this injection reached approximately USD 11 million in sales for the year ending July 2025.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sRMWo3w
via IFTTT